PharmaEssentia -

PharmaEssentia

Nov 07, 2024Jeremy ParkinsonFinance0

Company: PharmaEssentia CorporationBloomberg ticker: 6446 TTMarket cap: US$7,259mBackground: PharmaEssentia Corporation develops and distributes drugs to treat hepatitis, chronic myeloid leukemia, essential thrombocythemia, myeloid fibrosis, polycythemia vera, hepatitis, and cancer. The company was founded in 2003 by a group of Taiwanese-American executives and scientists from American biotech and pharmaceutical companies.

World Class Benchmarking of PharmaEssentia Corp

Profitable Growth rank of 6 was up compared to the prior period’s 9th rank

This is below average performance compared to 350 medium Health Care companies worldwide

Profitability rank of 6 was worse than its Growth rank of 2

Profitability rank of 6 was up compared to the prior period’s 9th rank

This is below average performance compared to peers

Growth rank of 2 was the same compared to the prior period’s 2nd rank

This is World Class performance compared to peers

More By This Author:Asian Stock: Jiangsu Hengrui PharmaceuticalsAsian Stock: Zhejiang China Commodities City GroupAsian Stock: President Chain Store Corp